Advanced search
Publication Cover
Journal of Drug Assessment Volume 9, 2020 - Issue 1
Journal homepage
1,023
Views
1
CrossRef citations to date
0
Altmetric
Diabetes

Clinical characteristics and patient treatment satisfaction with Humalog U-200 in patients with type 2 diabetes mellitus: an observational study

Jil MamzaDivision of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UK
,
Uchena AnyanwaguDivision of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UK
,
Mohammed AlkharaijiDivision of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UK
&
Iskandar IdrisDivision of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UKCorrespondence[email protected]
Pages 8-12 | Received 27 Jun 2019, Accepted 11 Nov 2019, Published online: 20 Dec 2019

References

  • AIFA (Italian Drug Agency) Nota Informativa Importante su Humalog KwikPen. [cited 2016 May 25] Available from: http://www.agenziafarmaco.gov.it/content/nota-informativa-importante-su-humalogkwikpen-25052016
  • Rees TM, Lennartz AH, Ignaut DA. A comparison of glide force characteristics between 2 prefilled insulin lispro pens. J Diabetes Sci Technol. 2015;9(2):316–319.
  • Clapham L. Injection technique education and follow-up: the key to ensuring optimal glycaemic control. J Diabetes Nurs. 2015;19:152–155.
  • Gentile S, Ceriello A, Pipicelli G, et al. Type 2 diabetes mellitus treatment habits in a specialized care setting: the START-DIAB study. Mediterranean J Nutr Metab. 2017;10(2):165–179.
  • Gentile S, Strollo F, De Rosa N, et al. Injection-related local side effects in the treatment of diabetes mellitus: a methodological approach and possible solutions. Consensus statement of AMD-OSDI study group on injection technique. 2016 Diabetes complications. Dover (DE): SM Group; [cited 2019 Oct 28]. Available from: http://www.smgebooks.com/diabetic-complications/chapters/DC-16-04.pdf
  • Gentile S, Fusco A, Colarusso S, et al. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence. Expert Opin Drug Saf. 2018;17:445–450.
  • Rissler J, Jørgensen C, Rye Hansen M, et al. Evaluation of the injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2217–2222.
  • Asakura T, Seino H, Kageyama M, et al. Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother. 2009;10(9):1389–1393.
  • Owens DR. Study to compare the injection force required for the following insulin pen devices: Lilly disposable pen, Novo FlexPen, and Solostar. J Diabetes Sci Technol. 2007;1:A134.
  • Shinabarger NI. Limited joint mobility in adults with diabetes mellitus. Phys Ther. 1987;67(2):215–218.
  • Gerrits GE, Landman GW, Nijenhuis-Rosien L, et al. Limited joint mobility syndrome in diabetes mellitus: a minireview. World J Diabetes. 2015;6(9):1108–1112.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.